| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/07/2011 | WO2011038473A1 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines |
| 04/07/2011 | US20110082287 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110082052 Phage displaying system expressing single chain antibody |
| 04/07/2011 | US20110081700 Methods of Purifying Recombinant Adamts13 and Other Proteins and Compositions Thereof |
| 04/07/2011 | US20110081381 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110081374 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 04/07/2011 | US20110081373 Attenuating mutations in the influenza a virus nep(=ns2) protein |
| 04/07/2011 | US20110081363 Compositions and methods for biological sample storage |
| 04/07/2011 | US20110081318 Viral compositions and methods |
| 04/07/2011 | CA2776534A1 Piscine reovirus diagnostic compositions |
| 04/07/2011 | CA2776195A1 Hepatitis c virus vaccine composition |
| 04/06/2011 | EP2305824A1 Multiple inducible gene regulation system |
| 04/06/2011 | EP2305710A2 Synthetic antibody phage libraries |
| 04/06/2011 | EP2305299A1 Chimeric alphavirus replicon particles |
| 04/06/2011 | EP2304024A2 Avian reoviridae |
| 04/06/2011 | EP2303322A1 Recombinant modified vaccinia virus measles vaccine |
| 04/06/2011 | EP2303320A1 Attenuated pestivirus |
| 04/06/2011 | EP1529113B1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 04/06/2011 | CN102007209A Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| 04/06/2011 | CN102007208A A newly identified human rhinovirus of HRV-C and methods and kits for detecting HRV-C |
| 04/06/2011 | CN102004151A Avian influenza virus H9 subtype hemagglutination inhibition antigen standard substance and preparation method thereof |
| 04/06/2011 | CN102002513A Efficiently-mediated DC gene transfer recombinant adenovirus |
| 04/06/2011 | CN102002503A Fungus resistant plants and their uses |
| 04/06/2011 | CN102002484A Preparation method and application of adenovirus-alphavirus hybrid virus |
| 04/06/2011 | CN102002483A Hematopoietic targeted helper adenovirus and application thereof |
| 04/06/2011 | CN102002482A Method for producing PRRS (Porcine Reproductive and Respiratory Syndrome) viruses |
| 04/06/2011 | CN102002481A Production method of porcine reproductive and respiratory syndrome virus |
| 04/06/2011 | CN102002476A Human mucous membrane living tissue model cultured in vitro as well as building method and application thereof |
| 04/06/2011 | CN102000328A Method for manufacturing Marek's disease vaccine by utilizing cell factory |
| 04/06/2011 | CN101173282B Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 04/05/2011 | US7919607 Nucleic acids encoding humanized anti-tag 72 CC49 antbodies |
| 04/05/2011 | US7919601 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests |
| 04/05/2011 | US7919592 Using microfiltration to remove microorganism from solution ccomprised of fibrinogen and/or antihemophilic factor |
| 04/05/2011 | US7919312 Self-replicating RNA molecule from hepatitis C virus |
| 04/05/2011 | US7919302 Solenopsis invicta virus |
| 04/05/2011 | US7919301 Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 04/05/2011 | US7919273 Structural variants of antibodies for improved therapeutic characteristics |
| 04/05/2011 | US7919096 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 04/05/2011 | CA2229163C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 03/31/2011 | WO2011035422A1 Method of preparing plant-derived vlps |
| 03/31/2011 | US20110077170 Hpiv-2 variants and their medical applications |
| 03/31/2011 | US20110076744 Compositions and methods to prevent AAV vector aggregation |
| 03/31/2011 | US20110076735 Microfluidic Devices |
| 03/31/2011 | US20110076672 Phage-Mediated Bioluminescent Detection of Yersinia Pestis |
| 03/31/2011 | US20110076304 Adapter molecule for the delivery of adenovirus vectors |
| 03/31/2011 | CA2772962A1 Method of preparing plant-derived vlps |
| 03/30/2011 | EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 03/30/2011 | EP2302039A1 Virus-like particles comprising HML-2 gag polypeptide |
| 03/30/2011 | EP2301953A1 Binding molecules for human factor VIII and factor VIII-like proteins |
| 03/30/2011 | EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/30/2011 | EP2301574A1 Virulent systemic feline calicivirus |
| 03/30/2011 | EP2301572A1 Cell-derived viral vaccines with low levels of residual cell DNA |
| 03/30/2011 | EP2300492A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 03/30/2011 | EP2300023A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
| 03/30/2011 | EP1799814B1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 03/30/2011 | EP1361890B1 Influenza vaccine formulations for intradermal delivery |
| 03/30/2011 | CN101998990A Improvements in preparation of influenza virus vaccine antigens |
| 03/30/2011 | CN101993894A Construction method of siRNA adenovirus carrier for restraining rat IL-1beta gene expression |
| 03/30/2011 | CN101993892A Eukaryotic expression vector for expressing shRNA (short hairpin Ribonucleic Acid) in manner of targeting in cancer cells |
| 03/30/2011 | CN101993498A Adenovirus vector avian influenza recombinant vaccine |
| 03/29/2011 | US7915396 Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49 |
| 03/29/2011 | US7915226 Methods of suppressing microglial activation |
| 03/29/2011 | CA2392653C Production of vaccines |
| 03/29/2011 | CA2228128C Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 03/24/2011 | WO2011035004A1 Virus like particles comprising target proteins fused to plant viral coat proteins |
| 03/24/2011 | WO2011034953A2 Lassa virus-like particles and methods of production thereof |
| 03/24/2011 | WO2010128524A3 Combined measles-malaria vaccine |
| 03/24/2011 | US20110070651 Recombinant viral vector for gene transfer into lymphoid cells |
| 03/24/2011 | US20110070624 Microwave resonant absorption method and device for viruses inactivation |
| 03/24/2011 | US20110070623 Self-inactivating helper adenoviruses for the production of high-capactiy recombinant adenoviruses |
| 03/24/2011 | US20110070267 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 03/24/2011 | US20110070264 Rabies virus vector systems and compositions and methods thereof |
| 03/24/2011 | US20110070263 Influenza hemagglutinin and neuraminidase variants |
| 03/24/2011 | US20110070262 Viral Vectors and Their Use in Therapeutic Methods |
| 03/24/2011 | US20110070254 Mutations in the influenza a virus ns1 gene and use thereof |
| 03/24/2011 | US20110070197 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070196 Hepatitis c virus inhibitors |
| 03/24/2011 | US20110070193 Anti-Infective Agents and Uses Thereof |
| 03/24/2011 | US20110070164 Post release modification of viral envelopes |
| 03/24/2011 | CA2774640A1 Virus like particles comprising target proteins fused to plant viral coat proteins |
| 03/24/2011 | CA2774475A1 Lassa virus-like particles and methods of production thereof |
| 03/23/2011 | EP2298938A1 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 03/23/2011 | EP2298924A2 Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA |
| 03/23/2011 | EP2298882A1 Recombinant virus, escherichia coli retaining the same and a process for production thereof |
| 03/23/2011 | EP2298791A1 Binding molecules for human factor VIII and factor VIII-like proteins |
| 03/23/2011 | EP2298343A1 Composition and method for increasing cell density in cell cultures infected with lentivirus |
| 03/23/2011 | EP2298067A1 Novel pesticidal toxins |
| 03/23/2011 | EP2297309A1 Pestivirus replicons providing an rna-based viral vector system |
| 03/23/2011 | EP2297186A2 Expression and assembly of human group c rotavirus-like particles and uses thereof |
| 03/23/2011 | EP2297185A1 Parvoviral capsid with incorporated gly-ala repeat region |
| 03/23/2011 | EP2296701A1 Cell-based systems for producing influenza vaccines |
| 03/23/2011 | CN101514334B Chicken infectivity bronchitis virus attenuated vaccine strain and application thereof |
| 03/22/2011 | US7910366 Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine |
| 03/22/2011 | US7910350 Adaptor-directed helper systems |
| 03/22/2011 | US7910110 Bacteriophage-mediated immunisation against hepatitis |
| 03/22/2011 | US7910093 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 03/22/2011 | CA2236159C Vp antigens of the jc virus |
| 03/22/2011 | CA2136958C Method for inhibition of viral morphogenesis |
| 03/17/2011 | WO2011031489A2 Umbilical cord amniotic membrane products |
| 03/17/2011 | WO2011029914A1 Method for the preparation of an influenza virus |